Harnessing Amino Acid Derivatives For Enhanced Viscosity Reduction And Stability Of Monoclonal Antibodies

In the fast-growing market of monoclonal antibodies (mAbs), there are an increasing number of indications that prefer intramuscular or subcutaneous injections. This delivery method has significant benefits for the patient, yet the high concentration of mAbs required can create difficulties in manufacturing and possible product loss. Read about recent research to identify excipients that reduce viscosity of high-concentration formulation and improve stability across a wide concentration range.